Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Predicting skeletal complications in metastatic breast cancer raises challenges.

× No keyword cloud information.

15 in total

1. Prognostic factors for skeletal complications from metastatic bone disease in breast cancer.

Authors: Janet E Brown; Richard J Cook; Allan Lipton; Luis Costa; Robert E Coleman
Journal: Breast Cancer Res Treat Date: 2010-06-24 Impact factor: 4.872

Review 2. Metastatic bone disease: clinical features, pathophysiology and treatment strategies.

Authors: R E Coleman
Journal: Cancer Treat Rev Date: 2001-06 Impact factor: 12.111

3. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group.

Authors: G N Hortobagyi; R L Theriault; L Porter; D Blayney; A Lipton; C Sinoff; H Wheeler; J F Simeone; J Seaman; R D Knight
Journal: N Engl J Med Date: 1996-12-12 Impact factor: 91.245

4. Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group.

Authors: R L Theriault; A Lipton; G N Hortobagyi; R Leff; S Glück; J F Stewart; S Costello; I Kennedy; J Simeone; J J Seaman; R D Knight; K Mellars; M Heffernan; D J Reitsma
Journal: J Clin Oncol Date: 1999-03 Impact factor: 44.544

5. Clinical benefit of zoledronic acid in patients with lung cancer and other solid tumors: analysis based on history of skeletal complications.

Authors: Vera Hirsh; N Simon Tchekmedyian; Lee S Rosen; Ming Zheng; Yong-Jiang Hei
Journal: Clin Lung Cancer Date: 2004-11 Impact factor: 4.785

Review 6. Skeletal complications of malignancy.

Authors: R E Coleman
Journal: Cancer Date: 1997-10-15 Impact factor: 6.860

7. American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer.

Authors: Bruce E Hillner; James N Ingle; Rowan T Chlebowski; Julie Gralow; Gary C Yee; Nora A Janjan; Jane A Cauley; Brent A Blumenstein; Kathy S Albain; Allan Lipton; Susan Brown
Journal: J Clin Oncol Date: 2003-09-08 Impact factor: 44.544

8. Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures.

Authors: H Mirels
Journal: Clin Orthop Relat Res Date: 1989-12 Impact factor: 4.176

9. A new parameter for measuring metastatic bone involvement by prostate cancer: the Bone Scan Index.

Authors: M Imbriaco; S M Larson; H W Yeung; O R Mawlawi; Y Erdi; E S Venkatraman; H I Scher
Journal: Clin Cancer Res Date: 1998-07 Impact factor: 12.531

10. Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000.

Authors: Kenji Shibuya; Colin D Mathers; Cynthia Boschi-Pinto; Alan D Lopez; Christopher J L Murray
Journal: BMC Cancer Date: 2002-12-26 Impact factor: 4.430

1 in total

1. Bone-targeted agents and skeletal-related events in breast cancer patients with bone metastases: the state of the art.

Authors: M Clemons; K A Gelmon; K I Pritchard; A H G Paterson
Journal: Curr Oncol Date: 2012-10 Impact factor: 3.677

1 in total